Here’s a structured FAQ for researchers working with MSL2 antibodies, organized by complexity and grounded in experimental methodologies:
Method: Combine RNAi knockdown with chromatin fractionation (e.g., CUT&RUN or ChIP). Validate loss of signal in Msl2 knockout cell lines (e.g., DT40 cells) .
Key controls:
Drosophila: Use for RIP assays to detect MSL2-RNA interactions (e.g., roX RNA co-localization) .
Mammals: Apply in allele-specific chromatin accessibility assays (e.g., ATAC-seq) to study biallelic gene regulation in hybrid mouse models .
Note: Cross-reactivity varies; test antibodies across species using overexpression systems.
PTM detection: Use proteasome inhibitors (ALLN/MG132) to stabilize ubiquitinated MSL2 forms. Resolve shifts via SDS-PAGE with anti-ubiquitin WB .
Isoforms: Combine size exclusion chromatography with WB to separate MSL2 complexes (e.g., MOF-MSL vs. free MSL2) .
Issue: In vitro MSL2-CLAMP cooperativity occurs genome-wide, but in vivo binding is X-chromosome-restricted .
Strategy:
Modification | Role | Antibody Validation Tip | Citation |
---|---|---|---|
H2B K34ub | DNA damage response | Use H2B K120R mutants to isolate K34ub | |
H4K16ac | Gene dosage compensation | Unaffected in MSL2 patient iPSCs |
Co-IP: For MSL2 interaction studies (e.g., with CLAMP or MOF), use mild crosslinkers (DSG) to preserve weak associations .
Multiplex assays: Pair MSL2 CUT&RUN with RNA FISH (roX) to study RNA-dependent targeting .
Epitope tags: Express HA/Flag-tagged MSL2 in knockout backgrounds to distinguish endogenous vs. exogenous protein .